Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 05:01 PM EDT

Revelation Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.5M 11.99M 5.25M 1.27M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
49.5K 100.61K 160.3K 148.73K
Total Current Assets
6.57M 12.15M 5.41M 1.91M
Property-Plant & Equipment
56.33K 65.08K 90.13K 130.14K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
56.33K 65.08K 90.13K 130.14K
Total Assets
6.62M 12.21M 5.5M 2.04M
Account Payables
783.62K 1.36M 554.21K 596.26K
Deferred Revenue
n/a n/a 2.91M n/a
Short-Term Debt
n/a n/a n/a 16.75K
Other Current Liabilities
2.25K 3.44M 367.48K 755.19K
Total Current Liabilities
1.91M 5.56M 4.45M 2.14M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 2.91M
Total Long-Term Liabilities
n/a n/a 554.21K 2.91M
Total Liabilities
1.91M 5.56M 4.45M 2.14M
Total Debt
n/a n/a n/a 16.75K
Common Stock
522.00 265.00 683.00 282.00
Retained Earnings
-40.51M -25.47M -25.35M -14.52M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
4.71M 6.65M 1.05M -99.47K
Total Investments
6.49B n/a n/a 48.3M